Clinical trials
Phase 4 Cancer Pain trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 5 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Unknown status | 5 |
| Terminated | 3 |
| Recruiting | 2 |
| Suspended | 1 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen Korea, Ltd., Korea | 3 |
| Mundipharma Korea Ltd | 3 |
| Taiwan Mundipharma Pharmaceuticals Ltd. | 2 |
| The University of Hong Kong | 2 |
| Amsterdam UMC, location VUmc | 1 |
| Cephalon | 1 |
| Deventer Ziekenhuis | 1 |
| Erasmus Medical Center | 1 |
| Fondazione IRCCS Policlinico San Matteo di Pavia | 1 |
| Fox Chase Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cancer Pain | 29 |
| Neoplasms | 9 |
| Pain | 8 |
| Agnosia | 3 |
| Breakthrough Pain | 2 |
| Chronic Pain | 2 |
| Opioid-Induced Constipation | 2 |
| Pancreatic Neoplasms | 2 |
| Acute Pain | 1 |
| Adenomatous Polyposis Coli | 1 |
Trials
Showing 51 to 29 of 29. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.